Viewing Study NCT04134260


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-02-21 @ 3:15 AM
Study NCT ID: NCT04134260
Status: RECRUITING
Last Update Posted: 2025-11-10
First Post: 2019-10-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
Sponsor: NRG Oncology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Adenocarcinoma View
None Stage I Prostate Cancer AJCC v8 View
None Stage II Prostate Cancer AJCC v8 View
None Stage III Prostate Cancer AJCC v8 View
None Stage IVA Prostate Cancer AJCC v8 View
Keywords: